SCHEMBL4907753

SCHEMBL4907753

Cc1ccc(SSc2ccc(C)c(C)c2)cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
CYP3A4 P08684 4/20 0.39
TDP1 Q9NUW8 3/20 0.39
TSHR P16473 3/20 0.39
ALOX15 P16050 1/20 0.39
HIF1A Q16665 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MAPT P10636 3/20 0.38
CYP1A2 P05177 3/20 0.38
CYP2D6 P10635 3/20 0.38
CYP2C9 P11712 3/20 0.38
NPC1 O15118 1/20 0.38
CYP2C19 P33261 1/20 0.38
RAB9A P51151 1/20 0.38
HPGD P15428 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
KMT2A Q03164 1/20 0.38
HTR1A P08908 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4908681 0.87 CYP3A4 (0.39) ALDH1A1CYP3A4TDP1TSHRALOX15
SCHEMBL26717446 0.84 ACHE (0.44) ALDH1A1CYP3A4TDP1HSD17B10MAPT
SCHEMBL30832958 0.82 ALDH1A1 (0.50) ALDH1A1CYP3A4TDP1TSHRMAPT
SCHEMBL47860 0.82 ALDH1A1 (0.50) ALDH1A1CYP3A4TDP1TSHRMAPT
SCHEMBL4908030 0.81 MAPT (0.36) ALDH1A1CYP3A4MAPTCYP1A2CYP2D6
SCHEMBL4908477 0.81 ALDH1A1 (0.34) ALDH1A1CYP3A4TDP1MAPTCYP1A2
SCHEMBL8442226 0.80 MAPT (0.50) ALDH1A1CYP3A4TDP1TSHRHSD17B10
SCHEMBL20345294 0.80 ALDH1A1 (0.53) ALDH1A1CYP3A4TDP1TSHRMAPT
SCHEMBL24595031 0.78 ALDH1A1 (0.40) ALDH1A1CYP3A4TDP1TSHRMAPT
SCHEMBL11360459 0.78 ALDH1A1 (0.40) ALDH1A1CYP3A4TDP1TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9949480-B2 N-alkylthio beta-lactams, alkyl-coenzyme A asymmetric disulfides, and aryl-alkyl disulfides as anti-bacterial agents UNIVERSITY OF SOUTH FLORIDA (US) 2018-04-24 US disclosed
US-20150327547-A1 N-ALKYLTHIO BETA-LACTAMS, ALKYL-COENZYME A ASYMMETRIC DISULFIDES, AND ARYL-ALKYL DISULFIDES AS ANTI-BACTERIAL AGENTS UNIVERSITY OF SOUTH FLORIDA (US) 2015-11-19 US disclosed
US-9096635-B2 N-alkylthio beta-lactams, alkyl-coenzyme A asymmetric disulfides, and aryl-alkyl disulfides as anti-bacterial agents UNIVERSITY OF SOUTH FLORIDA (US) 2015-08-04 US disclosed
WO-2015047702-A1 SELF CROSS-LINKABLE AND SELF CROSS-LINKED AROMATIC POLYIMIDE MEMBRANES FOR SEPARATIONS UOP LLC (US) 2015-04-02 WO disclosed
WO-2015047711-A1 POLYBENZOXAZOLE MEMBRANES FROM SELF-CROSS-LINKABLE AROMATIC POLYIMIDE MEMBRANES UOP LLC (US) 2015-04-02 WO disclosed
US-20140235565-A1 N-ALKYLTHIO BETA-LACTAMS, ALKYL-COENZYME A ASYMMETRIC DISULFIDES, AND ARYL-ALKYL DISULFIDES AS ANTI-BACTERIAL AGENTS UNIVERSITY OF SOUTH FLORIDA (US) 2014-08-21 US disclosed
US-8722937-B2 Asymmetric disulfides and aryl-alkyl disulfides as anti-bacterial agents UNIVERSITY OF SOUTH FLORIDA (US) 2014-05-13 US disclosed
US-20080182815-A1 Act against several infective agents, and most notably Bacillus spp. and Staphylococcus spp., including infection caused by methicillin-resistant Staphylococcus aureus (MRSA) UNIVERSITY OF SOUTH FLORIDA 2008-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182815-A1 Act against several infective agents, and most notably Bacillus spp. and Staphylococcus spp., including infection caused by methicillin-resistant Staphylococcus aureus (MRSA) SQOR, TST, COASY ALDH1A1 1205/4885CYP3A4 2055/4885TDP1 4748/4885
US-20150327547-A1 N-ALKYLTHIO BETA-LACTAMS, ALKYL-COENZYME A ASYMMETRIC DISULFIDES, AND ARYL-ALKYL DISULFIDES AS ANTI-BACTERIAL AGENTS COASY, SQOR, TST ALDH1A1 442/4885CYP3A4 1922/4885TDP1 4172/4885
US-20140235565-A1 N-ALKYLTHIO BETA-LACTAMS, ALKYL-COENZYME A ASYMMETRIC DISULFIDES, AND ARYL-ALKYL DISULFIDES AS ANTI-BACTERIAL AGENTS COASY, SQOR, TST ALDH1A1 442/4885CYP3A4 1922/4885TDP1 4172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.